
Webinar
Date: October 23, 2025 | Time: 4pm CET | 10am ET
Implementing Devyser AZF v2 and AZF Extension assays within the routine diagnostic laboratory setting
Microdeletions within the AZF region of Y chromosome
Drawing from her team’s experience in northern Sweden, Denise Rawcliffe will share:
- How Y-chromosomal microdeletions contribute to male infertility
- Updates from the 2023 international guidelines for AZF testing
- A step-by-step look at integrating the Devyser AZF v2 and AZF Extension assays into routine diagnostic workflows
Don’t miss the chance to engage directly with our speaker and get your questions answered during the live Q&A.
All registered participants will receive access to the webinar recording.
*Disclaimer: Devyser products are distributed worldwide. Not all intended uses and applications mentioned here are available in every country. Please consult your local sales representative for details.
Latest from the Devyser blog
View all
.png)
Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More

Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More